Permanent voice change resulting from Danazol therapy

Boothroyd CV, C V Boothroyd, F Lepre, Lepre F
The Australian & New Zealand journal of obstetrics & gynaecology · 1990 · vol. 30(3) , pp. 275–6 · doi:10.1111/j.1479-828x.1990.tb03232.x · PMID:2256868
Case report OA: closed public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-18 ⓘ

This case report describes a patient who experienced permanent voice changes following treatment with Danazol, highlighting a potential adverse effect of this medication.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Uterine Neoplasms Voice Adult Adult Danazol Danazol Danazol Endometriosis Endometriosis Female Female Humans Humans Uterine Neoplasms Uterine Neoplasms Voice Voice

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:10:20.980095+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine